Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 224
Filter
1.
J Clin Microbiol ; 59(2)2021 01 21.
Article in English | MEDLINE | ID: mdl-33177120

ABSTRACT

We evaluated the utility of the commercial Allplex genital ulcer real-time PCR multiplex assay for detecting Treponema pallidum, herpes simplex virus 1 (HSV-1) and 2 (HSV-2), and Chlamydia trachomatis serovar L (lymphogranuloma venereum [LGV]) DNA in mucosal and genital ulcers in the context of suspected syphilis. In total, 374 documented genital and mucosal ulcers from patients with and without syphilis presenting at several sexually transmitted infection (STI) centers in France from October 2010 to December 2016 were analyzed at the National Reference Center (CNR) for Bacterial STIs at Cochin Hospital in Paris. T. pallidum subsp. pallidum detection results were compared with the final diagnosis based on a combination of clinical examination, serological results, and in-house nested PCR (nPCR). Detections of HSV and LGV were validated against reference methods. We found that 44.6% of the 374 samples tested were positive for T. pallidum subsp. pallidum, 21% for HSV, and 0.8% for LGV. No positive results were obtained for 30.7% of samples, and 4.8% presented coinfections. For T. pallidum subsp. pallidum detection, the overall sensitivity was 80% (95% confidence interval [CI], 76.1 to 84.1%), specificity was 98.8% (95% CI, 97.7 to 99.9%), positive predictive value was 98.8% (95% CI, 97.7 to 99.9%) and negative predictive value was 80.2% (95% CI, 76.2 to 84.2%), with a rate of concordance with the reference method of 92.5% (k = 0.85). This PCR multiplex assay is suitable for T. pallidum subsp. pallidum detection in routine use and facilitates the simultaneous rapid detection of a broad panel of pathogens relevant in a context of suspected syphilis lesions.


Subject(s)
Syphilis , Treponema pallidum , France , Humans , Multiplex Polymerase Chain Reaction , Paris , Syphilis/diagnosis , Treponema pallidum/genetics , Ulcer
2.
J Eur Acad Dermatol Venereol ; 35(1): 17-26, 2021 Jan.
Article in English | MEDLINE | ID: mdl-32881110

ABSTRACT

Molluscum contagiosum is a benign viral epidermal infection associated with high risk of transmission. The guideline is focused on the sexually transmitted molluscum contagiosum. The diagnosis is clinical with characteristic individual lesions, termed 'mollusca', seen as dome-shaped, smooth-surfaced, pearly, firm, skin-coloured, pink, yellow or white papules, 2 - 5 mm in diameter with central umbilication. Dermoscopy may facilitate diagnosis. Therapeutic options are numerous, including physical treatments (cautery, curettage and cryotherapy), topical chemical treatments (e.g. podophyllotoxin and imiquimod) or waiting for spontaneous resolution in immunocompetent patients. In pregnancy, it is safe to use physical procedures (e.g. cryotherapy). Immunosuppressed patients develop severe and recalcitrant molluscum lesions that may require treatment with cidofovir, imiquimod or interferon. Patients with molluscum contagiosum infection should be offered to be screened for other sexually transmitted infections.


Subject(s)
Molluscum Contagiosum , Antiviral Agents/therapeutic use , Genitalia , Humans , Imiquimod/therapeutic use , Immunocompromised Host , Molluscum Contagiosum/diagnosis , Molluscum Contagiosum/therapy
3.
J Eur Acad Dermatol Venereol ; 35(3): 574-588, 2021 Mar.
Article in English | MEDLINE | ID: mdl-33094521

ABSTRACT

The 2020 edition of the European guideline on the management of syphilis is an update of the 2014 edition. Main modifications and updates include: -The ongoing epidemics of early syphilis in Europe, particularly in men who have sex with men (MSM) -The development of dual treponemal and non-treponemal point-of-care (POC) tests -The progress in non-treponemal test (NTT) automatization -The regular episodic shortage of benzathine penicillin G (BPG) in some European countries -The exclusion of azithromycin as an alternative treatment at any stage of syphilis -The pre-exposure or immediate post-exposure prophylaxis with doxycycline in populations at high risk of acquiring syphilis.


Subject(s)
Sexual and Gender Minorities , Syphilis , Anti-Bacterial Agents/therapeutic use , Europe , Homosexuality, Male , Humans , Male , Penicillin G Benzathine , Syphilis/diagnosis , Syphilis/drug therapy , Syphilis/epidemiology , Syphilis Serodiagnosis
4.
Ann Dermatol Venereol ; 147(5): 370-372, 2020 May.
Article in English | MEDLINE | ID: mdl-31952954

ABSTRACT

INTRODUCTION: Infectious cellulitis is a common disease, mostly affecting the lower extremities and the face but only rarely the genitalia. OBSERVATION: A 24-year-old male patient presented with acute erythematous edema of the penile shaft and foreskin present for 48hours. Gentle retraction of the foreskin revealed a short frenulum with a small area (2-3mm) of erosion. He had had unprotected genital and orogenital sex three days before with his usual female partner and reported tearing of the frenulum during intercourse. Ampicillin-sensitive Haemophilus parainfluenzae was isolated from the swab taken from the erosion of the frenulum. Clinical remission was obtained following oral administration of amoxicillin and clavulanic acid. DISCUSSION: We describe not only the first case of Haemophilus parainfluenzae-associated cellulitis of the penis but also the first report of penile cellulitis following erosion of a short frenulum during sexual intercourse.


Subject(s)
Cellulitis/microbiology , Foreskin/injuries , Haemophilus Infections , Haemophilus parainfluenzae , Lacerations/complications , Penile Diseases/microbiology , Cellulitis/etiology , Coitus , Haemophilus Infections/etiology , Humans , Male , Penile Diseases/etiology , Young Adult
6.
Ann Dermatol Venereol ; 146(1): 31-36, 2019 Jan.
Article in French | MEDLINE | ID: mdl-30366717

ABSTRACT

TREATMENT OF THE INITIAL INFECTION OR FIRST CLINICAL EPISODE OF GENITAL HERPES: An initial infection or first clinical episode of genital herpes is treated with oral aciclovir 200mg×5/d for 5 to 10 days depending on clinical status. The recommended dosage for valaciclovir is 1g×2/d and treatment duration is identical to that for aciclovir. TREATMENT OF HERPES RECURRING DURING PREGNANCY: There are no studies of the efficacy of antiviral therapy on the symptoms of genital recurring during pregnancy. However, initial anti-viral treatment using aciclovir or valaciclovir may be given where warranted by symptoms (i.e. duration and severity of symptoms). Valaciclovir may be used instead (equivalent efficacy but better safety data for aciclovir). Valaciclovir may be given at a dosage of 1×500mg b.i.d. p.o. for 5 days. PROPHYLACTIC ANTI-VIRAL TREATMENT DURING PREGNANCY: In female patients presenting an initial infection or infection recurring during pregnancy, although there is no demonstrated benefit for prophylactic treatment in reducing the risk of neonatal herpes, anti-viral prophylaxis is recommended after 36 WA (weeks' amenorrhoea) to limit the need for Caesarean section due to herpetic lesions. The recommended antivirals are aciclovir at a dosage of 400mg t.i.d p.o. or valaciclovir at a dosage of 500mg b.i.d. p.o. until delivery.


Subject(s)
Acyclovir/administration & dosage , Antiviral Agents/administration & dosage , Herpes Genitalis/drug therapy , Valacyclovir/administration & dosage , Dose-Response Relationship, Drug , Female , Herpes Genitalis/transmission , Humans , Infectious Disease Transmission, Vertical/prevention & control , Pregnancy , Pregnancy Complications, Infectious/drug therapy , Pregnancy Complications, Infectious/virology
10.
J Eur Acad Dermatol Venereol ; 31(9): 1425-1428, 2017 Sep.
Article in English | MEDLINE | ID: mdl-28714128

ABSTRACT

Pediculosis pubis is caused by Phthirus pubis. The disease can be sexually transmitted. Patients main complain is of itch in the pubic area. The parasite can be spotted with the naked eye and blue macules can be observed in the pubic area. First line therapy consists of permethrin or pyrethrins with piperonyl butoxide. Second line therapy contains phenothrin, malathion and oral ivermectin. Partner management needs a look-back period of time of 3 months. Pubic lice incidence is increased in populations groups living in crowded spaces with scarce sanitary conditions as in time of war or disaster.


Subject(s)
Insecticides , Lice Infestations , Pubic Bone , Female , Humans , Male , Insecticides/therapeutic use , Lice Infestations/diagnosis , Lice Infestations/drug therapy , Lice Infestations/epidemiology , Lice Infestations/transmission , Pubic Bone/parasitology , Sexual Partners
11.
J Eur Acad Dermatol Venereol ; 31(8): 1248-1253, 2017 Aug.
Article in English | MEDLINE | ID: mdl-28639722

ABSTRACT

Scabies is caused by Sarcoptes scabiei var. hominis. The disease can be sexually transmitted. Patients' main complaint is nocturnal itch. Disseminated, excoriated, erythematous papules are usually seen on the anterior trunk and limbs. Crusted scabies occurs in immunocompromised hosts and may be associated with reduced or absent pruritus. Recommended treatments are permethrin 5% cream, oral ivermectin and benzyl benzoate 25% lotion. Alternative treatments are malathion 0.5% aqueous lotion, ivermectin 1% lotion and sulphur 6-33% cream, ointment or lotion. Crusted scabies therapy requires a topical scabicide and oral ivermectin. Mass treatment of large populations with endemic disease can be performed with a single dose of ivermectin (200 micrograms/kg of bodyweight). Partner management needs a look-back period of 2 months. Screening for other STI is recommended. Patients and close contacts should avoid sexual contact until completion of treatment and should strictly observe personal hygiene rules when living in crowded spaces. Written information should be provided to suspected cases.


Subject(s)
Benzoates/therapeutic use , Ivermectin/therapeutic use , Permethrin/therapeutic use , Practice Guidelines as Topic , Scabies/drug therapy , Sexually Transmitted Diseases/drug therapy , Administration, Oral , Administration, Topical , Benzoates/administration & dosage , Contact Tracing , Europe , Humans , Ivermectin/administration & dosage , Permethrin/administration & dosage , Scabies/diagnosis , Scabies/transmission , Sexual Partners , Sexually Transmitted Diseases/diagnosis , Sexually Transmitted Diseases/transmission
SELECTION OF CITATIONS
SEARCH DETAIL
...